Physician
Retina Associates of Cleveland, INC.
Retina Associates of Cleveland, INC. was paid $11.19M by Medicaid between Jan 2018 and Nov 2024, across 18 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 77% of everything it billed.
33Billing provider infoRETINA ASSOCIATES OF CLEVELAND, INC.
BEACHWOOD, OH 44122
BEACHWOOD, OH 44122
33aNPI1912991225assigned 09/01/2005
33bProvider typeOphthalmology Physician
28Total paid$11.19M
24GClaims113,459
24DCodes billed18
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Ohio
Rank by total paid#1 of 155
Median peer was paid$10K
This provider vs. median1,076×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,142 | $184K | |
| 2019 | 11,880 | $374K | |
| 2020 | 13,684 | $1.34M | |
| 2021 | 19,575 | $2.26M | |
| 2022 | 20,541 | $2.64M | |
| 2023 | 23,383 | $2.76M | |
| 2024incomplete | 15,254 | $1.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 77% | 7,970 | 6,469 | $8.63M |
| 67028 | Intravitreal injection of a pharmacologic agent | 13% | 28,116 | 22,404 | $1.40M |
| 92134 | 3.3% | 44,481 | 37,811 | $374K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 5,889 | 5,166 | $210K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.4% | 9,150 | 7,751 | $152K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 4,544 | 3,991 | $108K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 3,836 | 3,392 | $95K |
| J3590 | Unclassified biologics | <1% | 1,372 | 868 | $53K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 876 | 763 | $49K |
| 92250 | <1% | 2,327 | 2,020 | $44K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 380 | 271 | $20K |
| 67210 | <1% | 69 | 50 | $18K |
6 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAUGHLIN, NICOLE (DIRECTOR OF REVENUE)